{"entity":{"type":"insider","cik":"0001421144","url":"/insider/0001421144","json_url":"/insider/0001421144.json","name":"Sanofi-Aventis Amerique du Nord S.N.C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":2,"first":"2010-02-11","last":"2010-10-14","span_basis":"filed_date"},"name_variants":[{"name":"Sanofi-Aventis Amerique du Nord S.N.C.","source":"filing","n_filings":2,"first_seen":"2010-02-11","last_seen":"2010-10-14"}],"transactions":[{"id":7667524,"accession":"0001181431-10-050881","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-050881","line_url":"/filing/0001181431-10-050881#line-1","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":null,"owner_name":"SANOFI-AVENTIS; Sanofi-Aventis Amerique du Nord S.N.C.","owner_display_name":"SANOFI-AVENTIS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock, $.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1017401.0,"shares_display":"1,017,401","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":28487228.0,"total_display":"28,487,228.00","total_whole":"28,487,228","shares_owned_after":15816953.0,"shares_owned_after_display":"15,816,953","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-13","filed_date":"2010-10-14","scope":"insider"},{"id":7763033,"accession":"0001181431-10-008611","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-008611","line_url":"/filing/0001181431-10-008611#line-4","is_derivative":false,"issuer_cik":"0000019520","issuer_name":"CHATTEM INC","issuer_ticker":"CHTT","issuer_name_source":null,"issuer_url":"/issuer/0000019520","owner_cik":null,"owner_name":"AVENTIS INC; River Acquisition Corp.; SANOFI-AVENTIS; Sanofi-Aventis Amerique du Nord S.N.C.","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, without par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":923268.0,"shares_display":"923,268","price_per_share":93.5,"price_display":"93.50","price_state":"stated","total_value":86325558.0,"total_display":"86,325,558.00","total_whole":"86,325,558","shares_owned_after":46399219.0,"shares_owned_after_display":"46,399,219","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-02-11","filed_date":"2010-02-11","scope":"insider"},{"id":7763031,"accession":"0001181431-10-008611","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-10-008611","line_url":"/filing/0001181431-10-008611#line-3","is_derivative":false,"issuer_cik":"0000019520","issuer_name":"CHATTEM INC","issuer_ticker":"CHTT","issuer_name_source":null,"issuer_url":"/issuer/0000019520","owner_cik":null,"owner_name":"AVENTIS INC; River Acquisition Corp.; SANOFI-AVENTIS; Sanofi-Aventis Amerique du Nord S.N.C.","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, without par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300936.0,"shares_display":"300,936","price_per_share":93.5,"price_display":"93.50","price_state":"stated","total_value":28137516.0,"total_display":"28,137,516.00","total_whole":"28,137,516","shares_owned_after":45475951.0,"shares_owned_after_display":"45,475,951","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-02-10","filed_date":"2010-02-11","scope":"insider"},{"id":7763028,"accession":"0001181431-10-008611","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-008611","line_url":"/filing/0001181431-10-008611","is_derivative":false,"issuer_cik":"0000019520","issuer_name":"CHATTEM INC","issuer_ticker":"CHTT","issuer_name_source":null,"issuer_url":"/issuer/0000019520","owner_cik":null,"owner_name":"AVENTIS INC; River Acquisition Corp.; SANOFI-AVENTIS; Sanofi-Aventis Amerique du Nord S.N.C.","owner_display_name":"AVENTIS INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, without par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29417226.0,"shares_display":"29,417,226","price_per_share":93.5,"price_display":"93.50","price_state":"stated","total_value":2750510631.0,"total_display":"2,750,510,631.00","total_whole":"2,750,510,631","shares_owned_after":44622694.0,"shares_owned_after_display":"44,622,694","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-02-09","filed_date":"2010-02-11","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000872589","name":"REGENERON PHARMACEUTICALS INC","url":"/issuer/0000872589","role":"Ten percent owner","n_filings":1,"first_seen":"2010-10-14","last_seen":"2010-10-14"},{"type":"issuer","type_label":"ISSUER","cik":"0000019520","name":"CHATTEM INC","url":"/issuer/0000019520","role":"Ten percent owner","n_filings":1,"first_seen":"2010-02-11","last_seen":"2010-02-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001421144","retrieved_at":"2026-08-23T10:15:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}